Skip to main content
/
HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.470
+0.041 (1.20%)
May 12, 2025, 4:00 PM - Market closed

HeartSciences Revenue

In the fiscal year ending April 30, 2024, HeartSciences had annual revenue of $18.60K with 261.17% growth.

Revenue (ttm)
$18.60K
Revenue Growth
+261.17%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
3.75M

Revenue Chart

Created with Highcharts 11.4.8HeartSciences Revenue - Annual64.18K​64.18K25.60K​25.60K14.37K​14.37K5.15K​5.15K18.60K​18.60K20202021202220232024-20K40K60K

History

Fiscal Year End Revenue Change Growth
Apr 30, 202418.60K13.45K261.17%
Apr 30, 20235.15K-9.22K-64.17%
Apr 30, 202214.37K-11.23K-43.86%
Apr 30, 202125.60K-38.58K-60.11%
Apr 30, 202064.18K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

HSCS News

More News